Neuren Pharmaceuticals
NEU.AX
#4924
Rank
NZ$2.36 B
Marketcap
$18.18
Share price
-0.54%
Change (1 day)
16.36%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2023: NZ$0.23 Billion

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.15 Billion. In 2023 the company made an earning of NZ$0.23 Billion, an increase over its 2022 earnings that were of NZ$0.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2023

Annual earnings

Year Earnings Change
2023NZ$0.23 B111519.63%
2022NZ$0.2 M-102.22%
2021-NZ$9.48 Million-20.06%
2020-NZ$11.85 Million-6.65%
2019-NZ$12.7 Million-449.8%
2018NZ$3.62 M-15.66%
2017NZ$4.3 M-125.7%
2016-NZ$16.75 Million-3.07%
2015-NZ$17.28 Million51.42%
2014-NZ$11.41 Million-32.7%
2013-NZ$16.95 Million87.47%
2012-NZ$9.05 Million10.96%
2011-NZ$8.15 Million-4.11%
2010-NZ$8.5 Million21025.61%
2009-NZ$0.05 Million-99.78%
2008-NZ$18.17 Million1.99%
2007-NZ$17.81 Million33.24%
2006-NZ$13.37 Million31.45%
2005-NZ$10.17 Million37.67%
2004-NZ$7.39 Million4.98%
2003-NZ$7.04 Million36.5%
2002-NZ$5.16 Million